Residential Electromagnetic Fields Not An Apparent Threat to Human Health

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 5 No 12
Volume 5
Issue 12

WASHINGTON--Exposure to residential electric and magnetic fields (EMFs) appears to pose no serious threat to human health, according to a National Research Council (NRC) committee. The panel reviewed more than 500 studies conducted in the 17 years since researchers reported that children living near high-voltage power lines were 1.5 times more likely to develop leukemia.

WASHINGTON--Exposure to residential electric and magnetic fields(EMFs) appears to pose no serious threat to human health, accordingto a National Research Council (NRC) committee. The panel reviewedmore than 500 studies conducted in the 17 years since researchersreported that children living near high-voltage power lines were1.5 times more likely to develop leukemia.

"Research has not shown in any convincing way that EMFs commonin homes can cause health problems, and extensive laboratory testshave not shown that EMFs can damage the cell in a way that isharmful to human health," said Charles F. Stevens, MD, PhD,of the Howard Hughes Medical Institute and the Salk Institute,who chaired the committee.

In the NRC review, no conclusive evidence emerged to link EMFsfound in homes to cancer, reproductive and development abnormalities,or learning and behavioral problems.

The NRC committee did, however, find a weak but nonetheless significantcorrelation between the incidence of childhood leukemia and proximityof large power lines. This link may result from factors otherthan EMFs, the panel said, including heavy traffic near powerlines, other types of local air pollution, and construction inolder homes that allows more pollutants to enter.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
Ongoing studies seek to evaluate immunotherapy in earlier lines of therapy for patients with early-stage Hodgkin lymphoma.
Strict inclusion criteria may disproportionately exclude racial minority populations from participating in breast cancer trials.
A paucity of prospective, well-vetted data to guide therapy in patients with rare lymphomas may result in a reliance on expert consensus guidelines.
1 expert in this video
1 expert in this video
1 expert in this video
Testing a patient’s genetics may influence decisions such as using longer courses of radiotherapy, says Rachit Kumar, MD.
Related Content